This webinar seeks to help Medical Affairs professionals better understand the business of life science companies, how their efforts impact the overall capability to commercialize a product, and contemporary ways to bridge the commercialization interface between their department and Marketing & Sales.

This virtual presentation will focus on 3 aspects of RWE: What are RWE and Real-World Data (RWD), and how are they different? What are relevant legal and regulatory considerations associated with using RWE for product label expansion? How have applicants successfully used RWE to obtain approval for new drug and medical device indications?

A panel of experts will discuss what they have learnt from the last 2 years to take forward to future congress offerings, while also exploring what HCPs want when joining congresses both virtually or face-to-face.